Overview
- 2 FDA inspections are on record.
- 2 inspections produced a Form 483.
- The most recent recorded inspection date is 2025-04-24.
At a glance
Inspections
2
Form 483s
2
EIRs
0
Last outcome
Form 483
Inspection history
FDA inspections on record, most recent first.
| Inspection | Category | Outcome | Form 483 |
|---|---|---|---|
| 22 Apr 2025 – 24 Apr 2025 | Human Drugs | WL | View 483 → |
| 11 Jun 2019 – 14 Jun 2019 | Human Drugs | 483 | View 483 → |
Observations on record
Form 483 observations cited at this site, most recent first.
24 Apr 2025
21 CFR 211.192
Investigations of discrepancies, failures
Cited by Damaris Y Hernandez, Pamela N Agaba
24 Apr 2025
21 CFR 211.22(d)
Procedures not in writing, fully followed
Cited by Damaris Y Hernandez, Pamela N Agaba
24 Apr 2025
21 CFR 211.63
Equipment Design, Size and Location
Cited by Damaris Y Hernandez, Pamela N Agaba
24 Apr 2025
21 CFR 211.84(d)(2)
Component identification test
Cited by Damaris Y Hernandez, Pamela N Agaba
Investigators
FDA investigators tied to this site in the record.
Recurring citations
CFR citation patterns observed across this site's inspections.
| Citation | What it covers | Cited |
|---|---|---|
| 21 CFR 211.165(e) | Cited across public-safe Form 483 observations | 5x |
| 21 CFR 211.22(d) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.84(d)(2) | Cited across public-safe Form 483 observations | 3x |
| 21 CFR 211.113(a) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.165(a) | Cited across public-safe Form 483 observations | 2x |
| FDCA 601(c) | Cited across public-safe Form 483 observations | 2x |
| 21 CFR 211.192 | Cited across public-safe Form 483 observations | 1x |
| 21 CFR 211.63 | Cited across public-safe Form 483 observations | 1x |
Full site report
Get the verbatim findings behind Absolutely Natural's 2 Form 483s
Source PDFs, verbatim observations, and recurring CFR citations, so your team knows what this site gets cited for.
- The site's full inspection history, with every Form 483 and its outcome
- Warning letters and recalls tied to the company behind it
- Whether recurring CFR citations get closed out or repeat